Molina Healthcare, Inc. (NYSE:MOH) Receives $355.67 Average PT from Analysts

Molina Healthcare, Inc. (NYSE:MOH) has earned a consensus rating of “Hold” from the thirteen brokerages that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $355.67.

A number of research analysts recently commented on MOH shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a report on Thursday, October 24th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Barclays lowered their price target on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a report on Friday, February 7th. Wells Fargo & Company upped their price objective on Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a report on Monday, November 4th. Finally, UBS Group decreased their price objective on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a report on Friday, February 7th.

Molina Healthcare Stock Down 1.3 %

NYSE MOH opened at $268.65 on Friday. The stock’s 50 day moving average is $294.57 and its 200 day moving average is $315.79. The company has a current ratio of 1.62, a quick ratio of 1.55 and a debt-to-equity ratio of 0.69. Molina Healthcare has a 12 month low of $262.32 and a 12 month high of $423.92. The stock has a market cap of $14.91 billion, a PE ratio of 13.15, a P/E/G ratio of 0.94 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Research analysts predict that Molina Healthcare will post 24.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Molina Healthcare

Large investors have recently modified their holdings of the stock. Colonial Trust Co SC increased its position in shares of Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company’s stock valued at $30,000 after purchasing an additional 93 shares during the last quarter. True Wealth Design LLC increased its position in shares of Molina Healthcare by 2,500.0% during the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Versant Capital Management Inc grew its position in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after acquiring an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new position in Molina Healthcare in the 4th quarter valued at $52,000. Finally, Capital Performance Advisors LLP bought a new position in Molina Healthcare in the 3rd quarter valued at $62,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.